stock.name

Macrogenics Inc

MGNX

Market Cap$320.68M
Close$

Compare Macrogenics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Macrogenics IncMacrogenics Inc-13.80%-22%-0.3
marketMarket Avg53.21.27%29%-1.3
HealthcareHealthcare Avg29.71.32%16%7.31.3
$13.75

Target Price by Analysts

214.6% upsideMacrogenics Target Price DetailsTarget Price
$-0.01

Current Fair Value

100.3% downside

Overvalued by 100.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$320.68 Million
Enterprise Value$170.46 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.37
Beta0.0
Outstanding Shares62,633,460
Avg 30 Day Volume2,473,898

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-13.8
PEG-36.99
Price to Sales-
Price to Book Ratio4.37
Enterprise Value to Revenue3.93
Enterprise Value to EBIT-0.93
Enterprise Value to Net Income-8
Total Debt to Enterprise0.2
Debt to Equity0.32

Revenue Sources

No data

ESG Score

No data

About Macrogenics Inc

CEO: Scott Koenig